Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetes.
Xianhua MaoKa Shing CheungJing-Tong TanLung-Yi MakChi Ho LeeChi-Leung ChiangHo-Ming ChengRex Wan-Hin HuiWai K LeungMan-Fung YuenWai Kay SetoPublished in: Alimentary pharmacology & therapeutics (2024)
Glycaemic control is an independent risk factor for HCC and liver-related mortality, and should be incorporated into oncoprotective strategies in the general DM population.